NCT00141115View on ClinicalTrials.gov

Levetiracetam for the Treatment of Alcohol Dependence and Anxiety

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
AlcoholismGeneralized Anxiety DisorderPanic DisorderSocial PhobiaAnxiety Disorders
Interventions
DRUG

levetiracetam

Levetiracetam 1500 mg BID

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

New York State Psychiatric Institute

OTHER

NCT00141115 - Levetiracetam for the Treatment of Alcohol Dependence and Anxiety | Biotech Hunter | Biotech Hunter